Portage Biotech Inc. PRTG
Set alert
6.81 0.00 0.00%
At close · Sep 3
6.81 Day range 7.60
52-week range unavailable
- Open
- 7.60
- Prev close
- 6.81
- Mkt cap
- 6.04M
- Vol
- 371.67K
- Avg vol
- 0
- EPS
- 0.00
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 6.81
- High
- 7.60
- Forward P/E
- -10.37
- Beta
- 99.48
- Short ratio
- 0.17
- Inst. own
- 17.80%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Aug 27, 2024
- 50-d avg
- 5.09
- 200-d avg
- 5.60
- 1y target
- 0.00
Analyst view
Consensus: none
Price target (mean) 0.00
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 0.00 | 0.00 – 0.00 | -5.46 | 0.0% | 0 | 0.0% | 0 |
| Next quarter | 0.00 | 0.00 – 0.00 | -5.69 | 0.0% | 0 | 0.0% | 0 |
| Current year | 0.00 | 0.00 – 0.00 | 0.00 | 0.0% | 0 | 0.0% | 0 |
| Next year | 0.00 | 0.00 – 0.00 | 0.00 | 0.0% | 0 | 0.0% | 0 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Jan 8, 2024 | HC Wainwright & Co. | Downgrade | Buy | Neutral |
| Nov 29, 2023 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Sep 7, 2023 | Cantor Fitzgerald | Reiterated | Overweight | Overweight |
| Aug 31, 2023 | Cantor Fitzgerald | Reiterated | Overweight | Overweight |
| Aug 2, 2023 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Aug 1, 2023 | Cantor Fitzgerald | Maintained | Overweight | Overweight |
| Dec 1, 2022 | HC Wainwright & Co. | Maintained | — | Buy |
| Nov 30, 2022 | Oppenheimer | Maintained | — | Outperform |
| Sep 20, 2022 | HC Wainwright & Co. | Maintained | — | Buy |
| Mar 7, 2022 | HC Wainwright & Co. | Initiated | — | Buy |
| Sep 21, 2021 | Oppenheimer | Initiated | — | Outperform |
| Sep 2, 2021 | B. Riley Securities | Initiated | — | Buy |
| Aug 19, 2021 | Cantor Fitzgerald | Initiated | — | Overweight |